- $1.57bn
- $2.45bn
- $1.31bn
- 96
- 71
- 68
- 93
Annual balance sheet for Conmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 27.4 | 20.8 | 28.9 | 24.3 | 24.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 177 | 184 | 191 | 242 | 238 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 417 | 460 | 581 | 616 | 640 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 133 | 128 | 133 | 137 | 156 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 190 | 197 | 297 | 311 | 278 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,043 | 981 | 1,552 | 1,466 | 1,344 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 709 | 785 | 746 | 834 | 963 |
Total Liabilities & Shareholders' Equity | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |
Total Common Shares Outstanding |